(PS) Nasiri v. Pfizer, Inc.
Opinion
ZABIULLAH NASIRI. No. 2:24-cv-2111-KJM-CKD (PS) Plaintiff, v. ORDER Defendant.
This matter was referred to a United States Magistrate Judge under Local Rule 302(c)(21). On April 17, 2025, the magistrate judge filed findings and recommendations, which contained notice that any objections to the findings and recommendations were to be filed within fourteen days. Plaintiff has not objected to the findings and recommendations. The court presumes that any findings of fact are correct. See Orand v. United States, 602 F.2d 207, 208 (9th Cir. 1979). The magistrate judge’s conclusions of law are reviewed de novo. See Robbins v. Carey, 481 F.3d 1143, 1147 (9th Cir. 2007) (“[D]eterminations of law by the magistrate judge are reviewed de novo by both the district court and [the appellate] court . . . .”). Having reviewed the file, the court finds the findings and recommendations to be supported by the record and by the proper analysis. ///// ] Accordingly, IT IS HEREBY ORDERED that: 1. The findings and recommendations filed April 7, 2025 (ECF No. 6), are adopted in full. 2. This action is dismissed for failure to prosecute. See Fed. R. Civ. P. 41(b). 3. The Clerk of Court is directed to close this case. DATED: May 15, 2025.
= | ¥ FU/ Fees STATES DISTRICT JUDGE
1]
Free access — add to your briefcase to read the full text and ask questions with AI
(PS) Nasiri v. Pfizer, Inc. ((PS) Nasiri v. Pfizer, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.